REQCX
Price
$41.95
Change
+$0.41 (+0.99%)
Updated
Jun 6 closing price
Net Assets
160.37M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

REQCX vs VITSX

Header iconREQCX vs VITSX Comparison
Open Charts REQCX vs VITSXBanner chart's image
Russell Sustnbl Aware Eq C
Price$41.95
Change+$0.41 (+0.99%)
VolumeN/A
Net Assets160.37M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
REQCX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REQCX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REQCX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. REQCX (160M). VITSX pays higher dividends than REQCX: VITSX (1.29) vs REQCX (0.28). REQCX was incepted earlier than VITSX: REQCX (17 years) vs VITSX (28 years). REQCX (2.24) is less costly to investors than VITSX (0.03). REQCX is a more actively managed with annual turnover of: 74.00 vs. VITSX (2.00). REQCX has a lower initial minimum investment than VITSX: REQCX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. REQCX (-4.94). VITSX return over 5 years is better than : 80.96 vs. REQCX (-16.68).
REQCXVITSXREQCX / VITSX
Total Expense Ratio2.140.037,133%
Annual Report Gross Expense Ratio2.240.037,467%
Fund Existence17 years28 years-
Gain YTD1.7710.833213%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets160M1.82T0%
Annual Yield % from dividends0.281.2922%
Returns for 1 year-4.9410.97-45%
Returns for 3 years-4.3740.35-11%
Returns for 5 years-16.6880.96-21%
Returns for 10 years-9.61180.49-5%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.